Insider Transactions in Q4 2022 at Tcr2 Therapeutics Inc. (TCRR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.34%
|
$11,000
$1.06 P/Share
|
|
Dec 13
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,659
-6.44%
|
$1,659
$1.06 P/Share
|
|
Dec 13
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,752
-4.16%
|
$4,752
$1.06 P/Share
|
|
Dec 12
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
10,613
-6.61%
|
$10,613
$1.1 P/Share
|
|
Dec 12
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,828
-5.49%
|
$5,828
$1.08 P/Share
|
|
Dec 12
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,610
-5.88%
|
$1,610
$1.1 P/Share
|
|
Dec 12
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,586
-3.86%
|
$4,586
$1.1 P/Share
|
|
Dec 09
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
10,325
-6.04%
|
$10,325
$1.13 P/Share
|
|
Dec 09
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,792
-4.87%
|
$2,792
$1.13 P/Share
|
|
Dec 09
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,561
-5.4%
|
$1,561
$1.13 P/Share
|
|
Dec 09
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,461
-3.62%
|
$4,461
$1.13 P/Share
|
|
Dec 08
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,410
-4.65%
|
$1,410
$1.25 P/Share
|
|
Dec 08
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
9,314
-5.17%
|
$9,314
$1.25 P/Share
|
|
Dec 08
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,511
-4.19%
|
$2,511
$1.25 P/Share
|
|
Dec 08
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,014
-3.15%
|
$4,014
$1.26 P/Share
|
|
Dec 07
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,378
-4.35%
|
$1,378
$1.28 P/Share
|
|
Dec 07
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
9,111
-4.81%
|
$9,111
$1.28 P/Share
|
|
Dec 07
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,457
-3.94%
|
$2,457
$1.28 P/Share
|
|
Dec 07
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,928
-2.99%
|
$3,928
$1.28 P/Share
|
|
Dec 06
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,361
-3.65%
|
$2,361
$1.33 P/Share
|
|
Dec 06
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
14,886
-7.29%
|
$14,886
$1.35 P/Share
|
|
Dec 06
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,327
-4.02%
|
$1,327
$1.33 P/Share
|
|
Dec 06
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,778
-2.8%
|
$3,778
$1.33 P/Share
|
|
Dec 05
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,302
-3.44%
|
$2,302
$1.37 P/Share
|
|
Dec 05
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
8,530
-4.01%
|
$8,530
$1.37 P/Share
|
|
Dec 05
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,291
-3.76%
|
$1,291
$1.37 P/Share
|
|
Dec 05
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,686
-2.66%
|
$3,686
$1.37 P/Share
|
|
Dec 02
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,273
-3.28%
|
$2,273
$1.39 P/Share
|
|
Dec 02
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
8,408
-3.8%
|
$8,408
$1.39 P/Share
|
|
Dec 02
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,273
-3.58%
|
$1,273
$1.39 P/Share
|
|
Dec 02
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,636
-2.56%
|
$3,636
$1.39 P/Share
|
|
Dec 01
2022
|
Angela Justice Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,576
+46.24%
|
-
|
|
Dec 01
2022
|
Garry E Menzel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
221,058
+50.0%
|
-
|
|
Dec 01
2022
|
Peter Olagunju Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,409
+48.41%
|
-
|
|
Dec 01
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
95,385
+40.13%
|
-
|